Illness	Number of cases
Volume depletion (E86)	171
Mental and behavioural disorders due to use of alcohol (F10.0)	103
Other respiratory disorders (J98.7)	97
Cystitis (N30.0)	94
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	84
Chronic obstructive pulmonary disease with acute exacerbation (J44.10)	81
Pneumonia organism unspecified - Lobar pneumonia unspecified organism (J18.1)	75
Other septicaemia - Sepsis unspecified organism (A41.9)	74
Type 2 diabetes mellitus without complications (E11.91)	69
Alcoholic liver disease (K70.3)	65

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	916
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	797
(9-984.7)	663
Computed tomography (CT) of the head without contrast medium (3-200)	609
Computed tomography of the chest with contrast medium (3-222)	587
Computed tomography of the abdomen with contrast medium (3-225)	577
Examination of the trachea and the bronchi by endoscopy (1-620.00)	473
(9-984.8)	442
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	337
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	302

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
127	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
101	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
74	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities	Mit dem UKSH: Herzchirurgie, Kardiologie zur Betreuung von Aortenklappenstenosen, Arbeitsgruppe CED (chronisch-entzündliche Darmerkrankungen). Mit dem UKE-Kardiologie zur Elektrophysiologie und mit dem Herzzentrum Dresden (Uniklinik, Elektrophysiologie)
Student training (clinical traineeship / internship year)	Die Sana Kliniken Lübeck sind akademisches Lehrkrankenhaus der Universitätsklinik Schleswig-Holstein.
Lectureships / teaching posts at universities of applied sciences	Die Sana Kliniken Lübeck sind Lehrkrankenhaus der Universität zu Lübeck und beteiligen sich an der Ausbildung von Medizinstudierenden im Rahmen von Untersuchungskursen, Famulaturen und dem Praktischen Jahr. Die praktische Ausbildung erfolgt unter Supervision von Assistenz- und Oberärzten.
Participation in multi-centre phase III/IV studies
Doctoral supervision	Unter anderem Betreuung von Bachelor- und Masterstudierenden (Fachhochschule Flensburg, Technische Hochschule Lübeck, Fachhochschule Osnabrück).
Participation in multi-centre Phase I/II studies